These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17414717)

  • 21. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.
    Weng L; Dyson J; Dazzi F
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8415-20. PubMed ID: 17494756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment.
    Cui W; Hosaka N; Miyake T; Wang X; Guo K; Cui Y; Li Q; Song C; Feng W; Li Q; Takaki T; Nishida T; Inaba M; Ikehara S
    Transplantation; 2008 Apr; 85(8):1151-8. PubMed ID: 18431236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of donor-derived thymic epithelial cells in [B6-->MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT).
    Takaki T; Hosaka N; Miyake T; Cui W; Nishida T; Inaba M; Ikehara S
    J Autoimmun; 2008 Dec; 31(4):408-15. PubMed ID: 19022623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous vascularized bone marrow transplantation to promote acceptance of hind limb allografts and its effects on central and peripheral chimerism.
    Kubitskiy A; Li J; Lanzetta M; Owen E; McCaughan GW; Bishop GA
    Transplantation; 2007 May; 83(9):1273-6. PubMed ID: 17496546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
    Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
    Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tolerance to pig antigens in mice grafted with fetal pig thymus/liver grafts.
    Lee LA; Gritsch HA; Arn JS; Emery DW; Glaser RM; Sablinski T; Sachs DH; Sykes M
    Transplant Proc; 1994 Jun; 26(3):1300-1. PubMed ID: 8029914
    [No Abstract]   [Full Text] [Related]  

  • 30. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells.
    Oikawa A; Ito K; Seguchi H; Okabe M; Migishima F; Eshima K; Azuma S; Song SY; Kaneko T; Shinohara N
    Transplantation; 2007 Jul; 84(1):23-30. PubMed ID: 17627233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the thymus in transplantation tolerance in miniature swine: V. Deficiency of the graft-to-thymus pathway of tolerance induction in recipients of cardiac transplants.
    Yamamoto S; Teranishi K; Kamano C; Samelson-Jones E; Arakawa H; Nobori S; Okumi M; Houser S; Shimizu A; Sachs DH; Yamada K
    Transplantation; 2006 Feb; 81(4):607-13. PubMed ID: 16495810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In utero transplantation of rat hematopoietic stem cells induces xenogeneic chimerism in mice.
    Rice HE; Hedrick MH; Flake AW
    Transplant Proc; 1994 Feb; 26(1):126-8. PubMed ID: 7906444
    [No Abstract]   [Full Text] [Related]  

  • 34. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial tolerance induced by transplantation of spatially separated thymuses: a cue for T cell retolerization in thymus grafts.
    Zhou J; Wang X; Luo G; He W; Cui Y; Tan J; Yang S; Yang J; Sun W; Song H; Xiang F; Yao Z; Liu D; Wu Y; Wu J
    Scand J Immunol; 2012 Apr; 75(4):401-8. PubMed ID: 22229764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.
    Steger U; Denecke C; Sawitzki B; Karim M; Jones ND; Wood KJ
    Transplantation; 2008 May; 85(9):1339-47. PubMed ID: 18475193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells.
    Arslan E; Klimczak A; Siemionow M
    Microsurgery; 2007; 27(3):190-9. PubMed ID: 17326192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.